Quiroga DT - Search Results

1

Mice lacking angiotensin type 2 receptor exhibit a sex-specific attenuation of insulin sensitivity.

Quiroga DT, Miquet JG, Gonzalez L, Sotelo AI, Muñoz MC, Geraldes PM, Giani JF, Dominici FP. Quiroga DT, et al. Mol Cell Endocrinol. 2019 Dec 1;498:110587. doi: 10.1016/j.mce.2019.110587. Epub 2019 Sep 17. Mol Cell Endocrinol. 2019. PMID: 31539597 Free PMC article.

2

Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice.

Muñoz MC, Burghi V, Miquet JG, Cervino IA, Quiroga DT, Mazziotta L, Dominici FP. Muñoz MC, et al. Among authors: quiroga dt. Peptides. 2017 Feb;88:37-45. doi: 10.1016/j.peptides.2016.12.003. Epub 2016 Dec 12. Peptides. 2017. PMID: 27979738

3

Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies.

Burghi V, Fernández NC, Gándola YB, Piazza VG, Quiroga DT, Guilhen Mario É, Felix Braga J, Bader M, Santos RAS, Dominici FP, Muñoz MC. Burghi V, et al. Among authors: quiroga dt. PLoS One. 2017 Aug 16;12(8):e0183278. doi: 10.1371/journal.pone.0183278. eCollection 2017. PLoS One. 2017. PMID: 28813513 Free PMC article.

4

Chronic administration of the angiotensin type 2 receptor agonist C21 improves insulin sensitivity in C57BL/6 mice.

Quiroga DT, Muñoz MC, Gil C, Pffeifer M, Toblli JE, Steckelings UM, Giani JF, Dominici FP. Quiroga DT, et al. Physiol Rep. 2018 Aug;6(16):e13824. doi: 10.14814/phy2.13824. Physiol Rep. 2018. PMID: 30156060 Free PMC article.

5

Participation of Gα_i-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways.

Burghi V, Echeverría EB, Sosa MH, Quiroga DT, Muñoz MC, Davio C, Monczor F, Fernández NC, Dominici FP. Burghi V, et al. Among authors: quiroga dt. Front Pharmacol. 2019 Feb 22;10:146. doi: 10.3389/fphar.2019.00146. eCollection 2019. Front Pharmacol. 2019. PMID: 30853914 Free PMC article.

6

Activation of AT₂ receptors prevents diabetic complications in female db/db mice by NO-mediated mechanisms.

Dominici FP, Veiras LC, Shen JZY, Bernstein EA, Quiroga DT, Steckelings UM, Bernstein KE, Giani JF. Dominici FP, et al. Among authors: quiroga dt. Br J Pharmacol. 2020 Oct;177(20):4766-4781. doi: 10.1111/bph.15241. Epub 2020 Sep 13. Br J Pharmacol. 2020. PMID: 32851652 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 36027389

8

Acute In Vivo Administration of Compound 21 Stimulates Akt and ERK1/2 Phosphorylation in Mouse Heart and Adipose Tissue.

Quiroga DT, Narvaéz Pardo JA, Zubiría MG, Barrales B, Muñoz MC, Giovambattista A, Dominici FP. Quiroga DT, et al. Int J Mol Sci. 2023 Nov 28;24(23):16839. doi: 10.3390/ijms242316839. Int J Mol Sci. 2023. PMID: 38069161 Free PMC article.

9

Preface.

Montúfar C, Córdova X, Gangotena S, Quiroga D, Grunauer M. Montúfar C, et al. Growth Horm IGF Res. 2018 Feb;38:1. doi: 10.1016/j.ghir.2017.12.015. Epub 2017 Dec 28. Growth Horm IGF Res. 2018. PMID: 29311008 No abstract available.

10

Preface.

Gangotena S, Montúfar C, Quiroga D, Grunauer M; Universidad San Francisco de Quito, Ecuador:. Gangotena S, et al. Growth Horm IGF Res. 2016 Jun;28:2. doi: 10.1016/j.ghir.2016.04.003. Growth Horm IGF Res. 2016. PMID: 27113158 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page